Prothrombin Complex Concentrate Market Size, Trends, Analysis, and Outlook By Product (3-factor PCC, 4-factor PCC), By Application (Acquired Coagulation Factor Deficiency, Congenital Coagulation Factor Deficiency, Others), By End-user (Hospital & Ambulatory Surgical Centers, Specialty Clinics, Others), by Region, Country, Segment, and Companies, 2024-2030
The global Prothrombin Complex Concentrate market size is poised to register 9.49% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Prothrombin Complex Concentrate market across By Product (3-factor PCC, 4-factor PCC), By Application (Acquired Coagulation Factor Deficiency, Congenital Coagulation Factor Deficiency, Others), By End-user (Hospital & Ambulatory Surgical Centers, Specialty Clinics, Others).
The Prothrombin Complex Concentrate market is experiencing steady growth due to the increasing prevalence of bleeding disorders, rising surgical procedures, and advancements in hemostasis management. Prothrombin complex concentrate (PCC) is a plasma-derived product containing clotting factors that aid in the rapid reversal of coagulopathy and control of bleeding episodes. With the expanding geriatric population and growing demand for emergency care services, the Prothrombin Complex Concentrate market is expected to witness further expansion.
Prothrombin Complex Concentrate Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Prothrombin Complex Concentrate market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Prothrombin Complex Concentrate survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Prothrombin Complex Concentrate industry.
Key market trends defining the global Prothrombin Complex Concentrate demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Prothrombin Complex Concentrate Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Prothrombin Complex Concentrate industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Prothrombin Complex Concentrate companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Prothrombin Complex Concentrate industry
Leading Prothrombin Complex Concentrate companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Prothrombin Complex Concentrate companies.
Prothrombin Complex Concentrate Market Study- Strategic Analysis Review
The Prothrombin Complex Concentrate market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Prothrombin Complex Concentrate industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Prothrombin Complex Concentrate Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Prothrombin Complex Concentrate Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Prothrombin Complex Concentrate market segments. Similarly, Strong end-user demand is encouraging Canadian Prothrombin Complex Concentrate companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Prothrombin Complex Concentrate market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Prothrombin Complex Concentrate Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Prothrombin Complex Concentrate industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Prothrombin Complex Concentrate market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Prothrombin Complex Concentrate Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Prothrombin Complex Concentrate in Asia Pacific. In particular, China, India, and South East Asian Prothrombin Complex Concentrate markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Prothrombin Complex Concentrate Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Prothrombin Complex Concentrate Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Prothrombin Complex Concentrate market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Prothrombin Complex Concentrate.
Prothrombin Complex Concentrate Market Company Profiles
The global Prothrombin Complex Concentrate market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Abeona Therapeutics Inc, Biotest AG, CSL, Grifols, S.A., Insud Pharma, Kedrion, Octapharma AG, Sanquin, Taibang Biological Group Co. Ltd, Takeda Pharmaceutical Company Ltd
Recent Prothrombin Complex Concentrate Market Developments
The global Prothrombin Complex Concentrate market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Prothrombin Complex Concentrate Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Product
3-factor PCC
4-factor PCC
By Application
Acquired Coagulation Factor Deficiency
Congenital Coagulation Factor Deficiency
Others
By End-User
Hospital & Ambulatory Surgical Centers
Specialty Clinics
Others
Geographical Segmentation:
Abeona Therapeutics Inc
Biotest AG
CSL
Grifols, S.A.
Insud Pharma
Kedrion
Octapharma AG
Sanquin
Taibang Biological Group Co. Ltd
Takeda Pharmaceutical Company Ltd
Formats Available: Excel, PDF, and PPT
The Prothrombin Complex Concentrate market is experiencing steady growth due to the increasing prevalence of bleeding disorders, rising surgical procedures, and advancements in hemostasis management. Prothrombin complex concentrate (PCC) is a plasma-derived product containing clotting factors that aid in the rapid reversal of coagulopathy and control of bleeding episodes. With the expanding geriatric population and growing demand for emergency care services, the Prothrombin Complex Concentrate market is expected to witness further expansion.
Prothrombin Complex Concentrate Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Prothrombin Complex Concentrate market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Prothrombin Complex Concentrate survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Prothrombin Complex Concentrate industry.
Key market trends defining the global Prothrombin Complex Concentrate demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Prothrombin Complex Concentrate Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Prothrombin Complex Concentrate industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Prothrombin Complex Concentrate companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Prothrombin Complex Concentrate industry
Leading Prothrombin Complex Concentrate companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Prothrombin Complex Concentrate companies.
Prothrombin Complex Concentrate Market Study- Strategic Analysis Review
The Prothrombin Complex Concentrate market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Prothrombin Complex Concentrate industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Prothrombin Complex Concentrate Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Prothrombin Complex Concentrate Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Prothrombin Complex Concentrate market segments. Similarly, Strong end-user demand is encouraging Canadian Prothrombin Complex Concentrate companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Prothrombin Complex Concentrate market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Prothrombin Complex Concentrate Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Prothrombin Complex Concentrate industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Prothrombin Complex Concentrate market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Prothrombin Complex Concentrate Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Prothrombin Complex Concentrate in Asia Pacific. In particular, China, India, and South East Asian Prothrombin Complex Concentrate markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Prothrombin Complex Concentrate Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Prothrombin Complex Concentrate Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Prothrombin Complex Concentrate market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Prothrombin Complex Concentrate.
Prothrombin Complex Concentrate Market Company Profiles
The global Prothrombin Complex Concentrate market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Abeona Therapeutics Inc, Biotest AG, CSL, Grifols, S.A., Insud Pharma, Kedrion, Octapharma AG, Sanquin, Taibang Biological Group Co. Ltd, Takeda Pharmaceutical Company Ltd
Recent Prothrombin Complex Concentrate Market Developments
The global Prothrombin Complex Concentrate market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Prothrombin Complex Concentrate Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Product
3-factor PCC
4-factor PCC
By Application
Acquired Coagulation Factor Deficiency
Congenital Coagulation Factor Deficiency
Others
By End-User
Hospital & Ambulatory Surgical Centers
Specialty Clinics
Others
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
Abeona Therapeutics Inc
Biotest AG
CSL
Grifols, S.A.
Insud Pharma
Kedrion
Octapharma AG
Sanquin
Taibang Biological Group Co. Ltd
Takeda Pharmaceutical Company Ltd
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Prothrombin Complex Concentrate Market Overview and Key Findings, 2024
1.2 Prothrombin Complex Concentrate Market Size and Growth Outlook, 2021- 2030
1.3 Prothrombin Complex Concentrate Market Growth Opportunities to 2030
1.4 Key Prothrombin Complex Concentrate Market Trends and Challenges
1.4.1 Prothrombin Complex Concentrate Market Drivers and Trends
1.4.2 Prothrombin Complex Concentrate Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Prothrombin Complex Concentrate Companies
2. PROTHROMBIN COMPLEX CONCENTRATE MARKET SIZE OUTLOOK TO 2030
2.1 Prothrombin Complex Concentrate Market Size Outlook, USD Million, 2021- 2030
2.2 Prothrombin Complex Concentrate Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. PROTHROMBIN COMPLEX CONCENTRATE MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. PROTHROMBIN COMPLEX CONCENTRATE MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Product
3-FACTOR PCC
4-FACTOR PCC
By Application
Acquired Coagulation Factor Deficiency
Congenital Coagulation Factor Deficiency
Others
By End-User
Hospital & Ambulatory Surgical Centers
Specialty Clinics
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Prothrombin Complex Concentrate Market, 2025
5.2 Asia Pacific Prothrombin Complex Concentrate Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Prothrombin Complex Concentrate Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Prothrombin Complex Concentrate Market, 2025
5.5 Europe Prothrombin Complex Concentrate Market Size Outlook by Type, 2021- 2030
5.6 Europe Prothrombin Complex Concentrate Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Prothrombin Complex Concentrate Market, 2025
5.8 North America Prothrombin Complex Concentrate Market Size Outlook by Type, 2021- 2030
5.9 North America Prothrombin Complex Concentrate Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Prothrombin Complex Concentrate Market, 2025
5.11 South America Pacific Prothrombin Complex Concentrate Market Size Outlook by Type, 2021- 2030
5.12 South America Prothrombin Complex Concentrate Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Prothrombin Complex Concentrate Market, 2025
5.14 Middle East Africa Prothrombin Complex Concentrate Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Prothrombin Complex Concentrate Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Prothrombin Complex Concentrate Market Size Outlook and Revenue Growth Forecasts
6.2 US Prothrombin Complex Concentrate Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Prothrombin Complex Concentrate Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Prothrombin Complex Concentrate Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Prothrombin Complex Concentrate Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Prothrombin Complex Concentrate Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Prothrombin Complex Concentrate Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Prothrombin Complex Concentrate Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Prothrombin Complex Concentrate Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Prothrombin Complex Concentrate Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Prothrombin Complex Concentrate Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Prothrombin Complex Concentrate Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Prothrombin Complex Concentrate Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Prothrombin Complex Concentrate Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Prothrombin Complex Concentrate Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Prothrombin Complex Concentrate Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Prothrombin Complex Concentrate Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Prothrombin Complex Concentrate Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Prothrombin Complex Concentrate Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Prothrombin Complex Concentrate Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Prothrombin Complex Concentrate Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Prothrombin Complex Concentrate Industry Drivers and Opportunities
7. PROTHROMBIN COMPLEX CONCENTRATE MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. PROTHROMBIN COMPLEX CONCENTRATE COMPANY PROFILES
8.1 Profiles of Leading Prothrombin Complex Concentrate Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Abeona Therapeutics Inc
Biotest AG
CSL
Grifols, S.A.
Insud Pharma
Kedrion
Octapharma AG
Sanquin
Taibang Biological Group Co. Ltd
Takeda Pharmaceutical Company Ltd
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Prothrombin Complex Concentrate Market Overview and Key Findings, 2024
1.2 Prothrombin Complex Concentrate Market Size and Growth Outlook, 2021- 2030
1.3 Prothrombin Complex Concentrate Market Growth Opportunities to 2030
1.4 Key Prothrombin Complex Concentrate Market Trends and Challenges
1.4.1 Prothrombin Complex Concentrate Market Drivers and Trends
1.4.2 Prothrombin Complex Concentrate Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Prothrombin Complex Concentrate Companies
2. PROTHROMBIN COMPLEX CONCENTRATE MARKET SIZE OUTLOOK TO 2030
2.1 Prothrombin Complex Concentrate Market Size Outlook, USD Million, 2021- 2030
2.2 Prothrombin Complex Concentrate Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. PROTHROMBIN COMPLEX CONCENTRATE MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. PROTHROMBIN COMPLEX CONCENTRATE MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Product
3-FACTOR PCC
4-FACTOR PCC
By Application
Acquired Coagulation Factor Deficiency
Congenital Coagulation Factor Deficiency
Others
By End-User
Hospital & Ambulatory Surgical Centers
Specialty Clinics
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Prothrombin Complex Concentrate Market, 2025
5.2 Asia Pacific Prothrombin Complex Concentrate Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Prothrombin Complex Concentrate Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Prothrombin Complex Concentrate Market, 2025
5.5 Europe Prothrombin Complex Concentrate Market Size Outlook by Type, 2021- 2030
5.6 Europe Prothrombin Complex Concentrate Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Prothrombin Complex Concentrate Market, 2025
5.8 North America Prothrombin Complex Concentrate Market Size Outlook by Type, 2021- 2030
5.9 North America Prothrombin Complex Concentrate Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Prothrombin Complex Concentrate Market, 2025
5.11 South America Pacific Prothrombin Complex Concentrate Market Size Outlook by Type, 2021- 2030
5.12 South America Prothrombin Complex Concentrate Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Prothrombin Complex Concentrate Market, 2025
5.14 Middle East Africa Prothrombin Complex Concentrate Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Prothrombin Complex Concentrate Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Prothrombin Complex Concentrate Market Size Outlook and Revenue Growth Forecasts
6.2 US Prothrombin Complex Concentrate Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Prothrombin Complex Concentrate Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Prothrombin Complex Concentrate Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Prothrombin Complex Concentrate Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Prothrombin Complex Concentrate Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Prothrombin Complex Concentrate Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Prothrombin Complex Concentrate Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Prothrombin Complex Concentrate Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Prothrombin Complex Concentrate Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Prothrombin Complex Concentrate Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Prothrombin Complex Concentrate Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Prothrombin Complex Concentrate Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Prothrombin Complex Concentrate Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Prothrombin Complex Concentrate Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Prothrombin Complex Concentrate Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Prothrombin Complex Concentrate Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Prothrombin Complex Concentrate Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Prothrombin Complex Concentrate Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Prothrombin Complex Concentrate Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Prothrombin Complex Concentrate Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Prothrombin Complex Concentrate Industry Drivers and Opportunities
7. PROTHROMBIN COMPLEX CONCENTRATE MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. PROTHROMBIN COMPLEX CONCENTRATE COMPANY PROFILES
8.1 Profiles of Leading Prothrombin Complex Concentrate Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Abeona Therapeutics Inc
Biotest AG
CSL
Grifols, S.A.
Insud Pharma
Kedrion
Octapharma AG
Sanquin
Taibang Biological Group Co. Ltd
Takeda Pharmaceutical Company Ltd
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
